Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa

BACKGROUND: No licensed human vaccines are available against enterotoxigenic Escherichia coli (ETEC), a major diarrhoeal pathogen affecting children in low- and middle-income countries and foreign travellers alike. ETVAX®, a multivalent oral whole-cell vaccine containing four inactivated ETEC strain...

Descripción completa

Detalles Bibliográficos
Autores principales: Kantele, Anu, Riekkinen, Marianna, Jokiranta, T Sakari, Pakkanen, Sari H, Pietilä, Jukka-Pekka, Patjas, Anu, Eriksson, Mari, Khawaja, Tamim, Klemets, Peter, Marttinen, Kati, Siikamäki, Heli, Lundgren, Anna, Holmgren, Jan, Lissmats, Agneta, Carlin, Nils, Svennerholm, Ann-Mari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658657/
https://www.ncbi.nlm.nih.gov/pubmed/37099803
http://dx.doi.org/10.1093/jtm/taad045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658657/
https://www.ncbi.nlm.nih.gov/pubmed/37099803
http://dx.doi.org/10.1093/jtm/taad045

Ejemplares similares